CRANBURY, N.J., May 4, 2012 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a biopharmaceutical company at the forefront of developing therapies for rare and orphan diseases, today announced a conference call and live audio webcast on Thursday, May 10, 2012 at 5 p.m. ET to discuss financial results for the first quarter ended March 31, 2012.
